Evolent Health, Inc.
EVH
$4.13
-$0.03-0.72%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.60% | -27.50% | -22.83% | -31.34% | -24.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.60% | -27.50% | -22.83% | -31.34% | -24.39% |
| Cost of Revenue | 8.21% | -34.93% | -29.77% | -36.34% | -28.82% |
| Gross Profit | -18.25% | 28.45% | 23.65% | -6.04% | -1.57% |
| SG&A Expenses | -5.65% | 31.65% | 19.26% | 10.16% | 11.51% |
| Depreciation & Amortization | -10.40% | 485.20% | -20.49% | -22.53% | -18.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.07% | -23.53% | -24.43% | -30.77% | -23.97% |
| Operating Income | -689.02% | -145.84% | 105.34% | -70.00% | -70.47% |
| Income Before Tax | 59.27% | -1,700.81% | 15.99% | -1,625.92% | -277.79% |
| Income Tax Expenses | -38.10% | -49.60% | 246.37% | -246.64% | 160.18% |
| Earnings from Continuing Operations | 58.79% | -1,781.99% | 9.82% | -1,346.68% | -273.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.79% | -1,781.99% | 9.82% | -1,346.68% | -273.95% |
| EBIT | -689.02% | -145.84% | 105.34% | -70.00% | -70.47% |
| EBITDA | -71.16% | 32.42% | 68.45% | -37.51% | -32.90% |
| EPS Basic | 62.01% | -1,344.87% | 13.17% | -691.56% | -183.48% |
| Normalized Basic EPS | 56.46% | -285.81% | 25.70% | -355.83% | -2,448.55% |
| EPS Diluted | 62.01% | -1,344.87% | 13.17% | -691.56% | -183.48% |
| Normalized Diluted EPS | 56.46% | -285.81% | 25.70% | -355.83% | -2,448.55% |
| Average Basic Shares Outstanding | -2.96% | -2.97% | -0.69% | 1.04% | 1.03% |
| Average Diluted Shares Outstanding | -2.96% | -2.97% | -0.69% | 1.04% | 1.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 1.00% | 0.58% | -1.07% | 0.76% |